Case Report
Year 2019,
Volume: 2 Issue: 1, 9 - 12, 01.01.2019
Abstract
References
- Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP. 2013. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Ann Rheum Dis, 72: 517–524.
- Colombel JF, Sandborn WJ, Reinisch W, Peyrin-Biroulet L, Panaccione R, Rutgeerts P, Hanauer SB, Ghosh S, Van Assche G, Robinson AM, Lau W, Maa JF, Huang B, Pappalardo B, Read H. 2018. Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. Aliment Pharmacol Ther, 47(2): 219-228.
- Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP, Watson KD, Lunt M, Symmons DP. 2011. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford), 50: 124–131.
- Horger MS, Pfannenberg C, Einsele H, Beck R, Hebart H, Lengerke C, Vonthein R, Wehrmann M, Faul C, Claussen C. 2006.Cytomegalovirus pneumonia after stem cell transplantation: correlation of CT findings with clinical outcome in 30 patients. AJR Am J Roentgenol, 187.
- Keser G, Direskeneli H, Akkoç N. 2005. TNF-α engelleyici ilaç kullanan olguların tedavi öncesinde tüberküloz açısından değerlendirilmesi ve alınması gerekli önlemler. RAED II. Uzlaşı Toplantısı Raporu 7.
- Moon JH, Kim EA, Lee KS, Kim TS, Jung KJ, Song JH. 2002. Cytomegalovirus pneumonia: high-resolution CT findings in ten non-AIDS immunocompromised patients. Korean J Radiol, 1 (2): 73-78.
- Nguyen Q, Estey E, Raad I, Rolston K, Kantarjian H, Jacobson K, Konoplev S, Ghosh S, Luna M, Tarrand J, Whimbey E. 2001. Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis, 32:539–545.
- Park SC, Jeen MY, Jeen YT. 2017. Approach to cytomegalovirus infections in patients with ulcerative colitis. Korean J Intern Med, 32(3): 383–392.
- Xue Y, Jiang L, Wan WG, Chen YM, Zhang J, Zhang ZC. 2016. Cytomegalovirus pneumonia in patients with rheumatic diseases after immunosuppressive therapy: A single center study in China. Chin Med J, 129:267-273.
- Willrich MAV, Murray DL, Snyder MR. 2015. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases. Transl Res, 165(2): 270-282.
Year 2019,
Volume: 2 Issue: 1, 9 - 12, 01.01.2019
Abstract
Nowadays, biological agents such as anti-tumor necrosis factor alpha (anti-TNFα) drugs are used in the treatment of many chronic inflammatory diseases, particularly in those cases that do not respond to conventional treatments. However, infrequently, opportunistic infections such as bacterial, viral, fungal and parasitic infections may develop in patients treated with anti-TNF therapy, and physicians should be cautious in terms of increased risk of infection when using these agents. In this case report, we present a case of bilateral Cytomegalovirus (CMV) pneumonia in an adalimumab treated patient due to ankylosing spondylitis.
References
- Burmester GR, Panaccione R, Gordon KB, McIlraith MJ, Lacerda AP. 2013. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease. Ann Rheum Dis, 72: 517–524.
- Colombel JF, Sandborn WJ, Reinisch W, Peyrin-Biroulet L, Panaccione R, Rutgeerts P, Hanauer SB, Ghosh S, Van Assche G, Robinson AM, Lau W, Maa JF, Huang B, Pappalardo B, Read H. 2018. Long‐term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis. Aliment Pharmacol Ther, 47(2): 219-228.
- Galloway JB, Hyrich KL, Mercer LK, Dixon WG, Fu B, Ustianowski AP, Watson KD, Lunt M, Symmons DP. 2011. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford), 50: 124–131.
- Horger MS, Pfannenberg C, Einsele H, Beck R, Hebart H, Lengerke C, Vonthein R, Wehrmann M, Faul C, Claussen C. 2006.Cytomegalovirus pneumonia after stem cell transplantation: correlation of CT findings with clinical outcome in 30 patients. AJR Am J Roentgenol, 187.
- Keser G, Direskeneli H, Akkoç N. 2005. TNF-α engelleyici ilaç kullanan olguların tedavi öncesinde tüberküloz açısından değerlendirilmesi ve alınması gerekli önlemler. RAED II. Uzlaşı Toplantısı Raporu 7.
- Moon JH, Kim EA, Lee KS, Kim TS, Jung KJ, Song JH. 2002. Cytomegalovirus pneumonia: high-resolution CT findings in ten non-AIDS immunocompromised patients. Korean J Radiol, 1 (2): 73-78.
- Nguyen Q, Estey E, Raad I, Rolston K, Kantarjian H, Jacobson K, Konoplev S, Ghosh S, Luna M, Tarrand J, Whimbey E. 2001. Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis, 32:539–545.
- Park SC, Jeen MY, Jeen YT. 2017. Approach to cytomegalovirus infections in patients with ulcerative colitis. Korean J Intern Med, 32(3): 383–392.
- Xue Y, Jiang L, Wan WG, Chen YM, Zhang J, Zhang ZC. 2016. Cytomegalovirus pneumonia in patients with rheumatic diseases after immunosuppressive therapy: A single center study in China. Chin Med J, 129:267-273.
- Willrich MAV, Murray DL, Snyder MR. 2015. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases. Transl Res, 165(2): 270-282.
There are 10 citations in total.
Details
| Primary Language | English |
|---|---|
| Subjects | Clinical Sciences |
| Journal Section | Case Report |
| Authors | |
| Publication Date | January 1, 2019 |
| Submission Date | September 4, 2018 |
| Acceptance Date | December 4, 2018 |
| Published in Issue | Year 2019 Volume: 2 Issue: 1 |